No information is present at this moment.
No information is present at this moment.
No information is present at this moment.
| Various rheumatological, pulmonary, gastrointestinal, haematological, nephrological, endocrinological, oncological, neurological, ocular and dermatological disorders, as well as severe allergic reactions, organ transplantation and prophylaxis of nausea and vomiting due to high-emetogenic chemotherapy |
|---|
|
| Laryngitis subglottica (pseudo-croup) |
|---|
|
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
There is a preference for the use of prednisolone over prednisone due to the (rare) occurrence of a conversion defect (11-beta-hydroxysteroid dehydrogenase reductase ectivity).
Closely monitor growth and development of children with long-term use; to avoid growth inhibition, aim for alternating doses.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Mineralocorticoids | ||
|---|---|---|
| H02AA02 | ||
| Glucocorticoids | ||
|---|---|---|
| H02AB02 | ||
| H02AB09 | ||
| H02AB04 | ||
| H02AB06 | ||
| H02AB08 | ||